Green Thumb Industries (GTBIF) Cost of Revenue (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Cost of Revenue came in at $156.5 million in Q1 2026, up 14.88% YoY from $136.3 million in Q1 2025, and down 7.8% on a QoQ basis from $169.8 million in Q4 2025.
Green Thumb Industries (GTBIF) Cost of Revenue (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Cost of Revenue data on file, last reported at $156.5 million in Q1 2026.
- Quarterly Cost of Revenue rose 14.88% year-over-year to $156.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $620.7 million (up 14.64% YoY) and the FY2025 annual result came in at $600.4 million, up 12.01% from the prior year.
- Cost of Revenue declined to $156.5 million in Q1 2026, from $169.8 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $169.8 million in Q4 2025 to a low of $119.7 million in Q1 2022.
- A 5-year average of $137.3 million and a median of $135.5 million in 2023 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2022 — Cost of Revenue soared 43.19% — and 2024, when it fell 1.64%.
- Tracing GTBIF's Cost of Revenue over 5 years: stood at $135.3 million in 2022, then climbed by 0.19% to $135.5 million in 2023, then advanced by 0.52% to $136.3 million in 2024, then gained by 24.62% to $169.8 million in 2025, then dropped by 7.8% to $156.5 million in 2026.
- The last three Cost of Revenue figures came in at $156.5 million (Q1 2026), $169.8 million (Q4 2025), and $147.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Green Thumb Industries | 1.66 Bn | 1.37 Bn | 137.87 Mn | 168.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 168.81 Mn |
| Jun 30, 2026 | 168.81 Mn |
| Mar 31, 2026 | 156.55 Mn |
| Mar 31, 2026 | 156.55 Mn |
| Dec 31, 2025 | 169.79 Mn |
| Dec 31, 2025 | 169.79 Mn |
| Sep 30, 2025 | 147.34 Mn |
| Sep 30, 2025 | 147.34 Mn |
| Jun 30, 2025 | 147.00 Mn |
| Jun 30, 2025 | 147.00 Mn |
| Mar 31, 2025 | 136.27 Mn |
| Mar 31, 2025 | 136.27 Mn |
| Dec 31, 2024 | 136.25 Mn |
| Dec 31, 2024 | 136.25 Mn |
| Sep 30, 2024 | 139.27 Mn |
| Sep 30, 2024 | 139.27 Mn |
| Jun 30, 2024 | 129.63 Mn |
| Jun 30, 2024 | 129.63 Mn |
| Mar 31, 2024 | 130.88 Mn |
| Mar 31, 2024 | 130.88 Mn |